Eversense 365 implantable CGM named Best New Diabetes Medtech 2025
- Samantha
- May 9
- 2 min read
News from Ascensia Diabetes Care, 8 May 2025
Image courtesy of Ascencia Diabetes Care.
Eversense 365 CGM - an implantable sensor for diabetes management - has been named the Best New Technology Solution for Diabetes Management in the 2025 annual MedTech Breakthrough Awards Program. This follows a Gold award at last month's Edison Best New Products Awards, where Eversense beat Abbot’s Lingo CGM.
Eversense 365 is the only long-term CGM system available, offering people with diabetes a truly differentiated CGM experience, providing one year of exceptionally accurate monitoring with minimal interruptions.
The tiny implantable sensor and unique approach to CGM also allows people to overcome common frustrations and interruptions experienced with traditional short-term CGMs, so they can focus on managing their diabetes and not their device.
Eversense 365 is currently available in the US and indicated for people with diabetes 18 years and older; an application for European CE Mark registration has been filed to allow Eversense 365 to be marketed in Europe.
Eversense 365 has also recently partnered with Sequel Med Tech to create the first automated insulin delivery system with a one-year CGM. The integrated system is expected to launch in Q3 of 2025.
For more information, see the press release here.
Thank your for reading. If you have any comments on this blog or the Dexcom G7 15 day wear that would be helpful to other members, please email us - hello@whatcgm.com
If you're not currently a member of our community please join us by subscribing here. We look forward to welcoming you!
Disclaimer
Blogs and publications on this website are independent of any involvement by medtech companies or diabetes related charities. To ensure there is no bias, we do not accept any products, freebies or other material from any medtech provider. Except where credited otherwise, all materials are copyright ©️What CGM.
Content here and on our website www.whatcgm.com does not constitute medical advice or replace the relationship between you and healthcare professionals nor the advice you receive from them. The author of this blog has type 1 diabetes and uses the FreeStyle Libre 2 Plus which is provided on NHS prescription.
Comments